BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27381214)

  • 1. PLAG1 expression is maintained in recurrent pleomorphic adenoma.
    de Brito BS; Gaspar NG; Egal ES; Sanchez-Romero C; Martins AS; Tincani ÁJ; de Oliveira Gondak R; de Almeida OP; Kowalski LP; Altemani A; Mariano FV
    Virchows Arch; 2016 Oct; 469(4):477-81. PubMed ID: 27381214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
    Andreasen S; von Holstein SL; Homøe P; Heegaard S
    Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
    Avadhani V; Cohen C; Siddiqui MT
    Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland.
    Matsuyama A; Hisaoka M; Hashimoto H
    Pathol Int; 2012 Jan; 62(1):1-7. PubMed ID: 22192798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
    Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.
    Martins C; Fonseca I; Roque L; Pereira T; Ribeiro C; Bullerdiek J; Soares J
    Mod Pathol; 2005 Aug; 18(8):1048-55. PubMed ID: 15920557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
    Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
    Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
    Foo WC; Jo VY; Krane JF
    Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
    Bahrami A; Dalton JD; Shivakumar B; Krane JF
    Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
    Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
    Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic localization of PLAG1 (pleomorphic adenoma gene 1) in pleomorphic adenoma of the salivary gland: cytogenetic evidence of common origin of phenotypically diverse cells.
    Debiec-Rychter M; Van Valckenborgh I; Van den Broeck C; Hagemeijer A; Van de Ven WJ; Kas K; Van Damme B; Voz ML
    Lab Invest; 2001 Sep; 81(9):1289-97. PubMed ID: 11555676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
    El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
    Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.
    Zhao X; Ren W; Yang W; Wang Y; Kong H; Wang L; Yan L; Xu G; Fei J; Fu J; Zhang C; Wang Z
    Int J Cancer; 2006 Feb; 118(3):643-8. PubMed ID: 16108035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
    Rotellini M; Palomba A; Baroni G; Franchi A
    Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
    Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
    Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic adenoma: detection of PLAG1 rearrangement-positive tumor components using whole-slide fluorescence in situ hybridization.
    Murase T; Ishibashi K; Okumura Y; Ueda K; Nakano S; Fujii K; Masaki A; Nagao T; Inagaki H
    Hum Pathol; 2022 Feb; 120():26-34. PubMed ID: 34906590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
    Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
    Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
    Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.